发明名称 QUINAZOLINE DERIVATIVES
摘要 A B S T R A C T QUINAZOLINE DERIVATIVES The invention concerns quinazoline derivatives of the formula I I wherein m is 1, 2 or 3 and each R1 includes hydroxy, amino, ureido, hydroxyamino, trifluoromethoxy, (1-4C)alkyl, (1-4C)alkoxy and (1-3C)alkylenedioxy; and and Q is a 9- or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen heteroatoms and optionally containing a further heteroatom selected from nitrogen, oxygen and sulphur, or Q is a 9- or 10-membered bicyclic aryl moiety which heterocyclic or aryl moiety may optionally bear one or two substituents selected from halogeno, hydroxy, oxo, amino, nitro, carbamoyl, (1-4C)alkyl, (1-4C)alkoxy, (1-4C)alkylamino, di-¢(1-4C)alkyl!amino and (2-4C)alkanoylamino; or a pharmaceutically-acceptable salt thereof; processes for their preparation; pharmaceutical compositions containing them; and the use of the receptor tyrosine kinase inhibitory properties of the compounds in the treatment of cancer.
申请公布号 CA2103383(A1) 申请公布日期 1994.06.11
申请号 CA19932103383 申请日期 1993.11.18
申请人 ZENECA LIMITED 发明人 BARKER, ANDREW J.;BROWN, DEARG S.
分类号 A61K31/505;A61K31/517;A61K31/519;A61P35/00;A61P43/00;C07D239/94;C07D401/04;C07D401/12;C07D401/14;C07D403/04;C07D403/12;C07D403/14;C07D409/12;C07D413/12;C07D413/14;C07D417/12;C07D417/14;C07D491/04;C07D491/056;(IPC1-7):C07D401/00;C07D403/00;C07D413/00;C07D417/00;A61K31/535;A61K31/54 主分类号 A61K31/505
代理机构 代理人
主权项
地址